EMA/PE/0000184114
Submitted by Anonymous (not verified) on 14 July 2026 - 13:28
EMA/PE/0000184114
EMA/PE/0000242080
Submitted by Anonymous (not verified) on 14 July 2026 - 13:25
EMA/PE/0000242080
Human medicines European public assessment report (EPAR): Dyrupeg, pegfilgrastim, Date of authorisation: 28/03/2025, Revision: 4, Status: Authorised
Submitted by Anonymous (not verified) on 14 July 2026 - 13:23
Human medicines European public assessment report (EPAR): Dyrupeg, pegfilgrastim, Date of authorisation: 28/03/2025, Revision: 4, Status: Authorised
EMA/PE/0000221389
Submitted by Anonymous (not verified) on 14 July 2026 - 13:22
EMA/PE/0000221389
Human medicines European public assessment report (EPAR): Zefylti, filgrastim, Date of authorisation: 12/02/2025, Revision: 3, Status: Authorised
Submitted by Anonymous (not verified) on 14 July 2026 - 13:15
Human medicines European public assessment report (EPAR): Zefylti, filgrastim, Date of authorisation: 12/02/2025, Revision: 3, Status: Authorised
Changing the labelling and package leaflet (Article 61(3) notifications)
Submitted by Anonymous (not verified) on 14 July 2026 - 13:00
Changing the labelling and package leaflet (Article 61(3) notifications)
EMA/PE/0000232449
Submitted by Anonymous (not verified) on 14 July 2026 - 12:45
EMA/PE/0000232449
EMA/PE/0000232782
Submitted by Anonymous (not verified) on 14 July 2026 - 12:27
EMA/PE/0000232782
EMA/PE/0000232780
Submitted by Anonymous (not verified) on 14 July 2026 - 12:22
EMA/PE/0000232780
EMA/PE/0000239504
Submitted by Anonymous (not verified) on 14 July 2026 - 10:59
EMA/PE/0000239504